Altered propionate metabolism contributes to tumor progression and aggressiveness

[1]  K. Hunter,et al.  In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition. , 2020, Molecular cell.

[2]  R. de Cabo,et al.  Age-induced methylmalonic acid accumulation promotes tumor progression , 2020, Nature.

[3]  M. Mann,et al.  Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition. , 2020, Cancer discovery.

[4]  J. Blenis,et al.  Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization. , 2019, Cancer cell.

[5]  Norikazu Masuda,et al.  Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples , 2019, Scientific Reports.

[6]  O. Straume,et al.  Are 90% of deaths from cancer caused by metastases? , 2019, Cancer medicine.

[7]  J. Blenis,et al.  ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation , 2019, Proceedings of the National Academy of Sciences.

[8]  S. Fendt,et al.  Measuring In Vivo Tissue Metabolism Using 13C Glucose Infusions in Mice. , 2018, Methods in molecular biology.

[9]  Sarah Jeanfavre,et al.  Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass , 2017, Science.

[10]  Navdeep S. Chandel,et al.  Fundamentals of cancer metabolism , 2016, Science Advances.

[11]  S. Campello,et al.  Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents , 2016, Oncotarget.

[12]  D. Gupta,et al.  Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer , 2016, PloS one.

[13]  Ashutosh Kumar Singh,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[14]  Edward L. Huttlin,et al.  The BioPlex Network: A Systematic Exploration of the Human Interactome , 2015, Cell.

[15]  B. Zhou,et al.  Inflammation fuels tumor progress and metastasis. , 2015, Current pharmaceutical design.

[16]  J. Asara,et al.  A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue , 2012, Nature Protocols.

[17]  Edi Brogi,et al.  Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs , 2011, Nature Medicine.

[18]  J. Blenis,et al.  ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. , 2010, Molecular cell.

[19]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[20]  Joseph,et al.  Imagable 4T1 model for the study of late stage breast cancer , 2008, BMC Cancer.

[21]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[23]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[24]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.

[25]  David Padua,et al.  Roles of TGFβ in metastasis , 2009, Cell Research.

[26]  F. Miller,et al.  Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. , 1983, Invasion & metastasis.